Who is sponsoring NCT05661253?

NCT05661253 is sponsored by Zagazig University.

What drugs are being tested in NCT05661253?

Interventions in NCT05661253: 25 ml of bupivacaine 0.25% via serratus anterior block, 25 ml of bupivacaine 0.25% via modified serratus anterior palne block.

What condition does NCT05661253 study?

NCT05661253 studies Postoperative Pain, Acute.

Is NCT05661253 still recruiting?

NCT05661253 is currently status unknown. Last updated 29 August 2023.

Last reviewed 2023-08-29 · How we verify

NCT05661253

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modified Versus Conventional Serratus Anterior Plane Block

Status unknown NA Last updated 29 August 2023

What this trial tests

NA trial testing 25 ml of bupivacaine 0.25% via serratus anterior block in Postoperative Pain, Acute in 99 participants. Status unknown.

Timeline

2 December 2022

Primary endpoint
2 October 2023

30 October 2023

Quick facts

Lead sponsor	Zagazig University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	99
Start date	2 December 2022
Primary completion	2 October 2023
Estimated completion	30 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

25 ml of bupivacaine 0.25% via serratus anterior block — full drug profile →
25 ml of bupivacaine 0.25% via modified serratus anterior palne block — full drug profile →

Conditions studied

Postoperative Pain, Acute — all drugs for Postoperative Pain, Acute →

Sponsor

Zagazig University

Who can join

Adults 21 to 60, any sex, with Postoperative Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

comparing preemptive analgesia with ultrasound guided modified serratus anterior plane block versus ultrasound guided serratus anterior plane block

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ultrasound-guided modified versus conventional serratus anterior plane block as a preemptive analgesic for unilateral video-assisted thoracoscopic surgery.
Abd Ellatif SE, Galal Eldin AM, Ali ES, Fathi HM. · · 2025 · PMID 40883665 · DOI 10.1186/s12871-025-03314-5

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05661253 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 29 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05661253.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing